UIMC1


Description

The UIMC1 (ubiquitin interaction motif containing 1) is a protein-coding gene located on chromosome 5.

RAP80, the protein product of the UIMC1 gene, is a core component of the deubiquitin complex BRCA1-A. Other core components of the BRCA1-A complex are the BRCC36 protein (BRCC3 gene), BRE protein (BRE (gene)), and MERIT40 protein (BABAM1 gene). BRCA1, as distinct from BRCA1-A, is employed in the repair of chromosomal damage with an important role in the error-free homologous recombinational (HR) repair of DNA double-strand breaks. Sequestration of BRCA1 away from the DNA damage site suppresses homologous recombination and redirects the cell in the direction of repair by the process of non-homologous end joining (NHEJ).

UIMC1, also known as RAP80, is a ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. It plays a crucial role in the BRCA1-A complex by binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA damage sites. This binding targets the BRCA1-BARD1 heterodimer to these sites, promoting DNA repair at double-strand breaks (DSBs). The BRCA1-A complex also has deubiquitinase activity, specifically removing 'Lys-63'-linked ubiquitin from histones H2A and H2AX. While it can weakly bind monoubiquitin, its affinity for 'Lys-63'-linked ubiquitin is much stronger. UIMC1 may interact with monoubiquitinated histones H2A and H2B, but the significance of this interaction is unclear in vivo. It does not bind Lys-48'-linked ubiquitin. UIMC1 might indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1.

UIMC1 is also known as RAP80, X2HRIP110.

Associated Diseases


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.